News-Pyrotech

News

Pyrotech Therapeutics Announces the Completion of Hundreds of Millions of RMB in Series A+ Financing

2024-05-24
The first novel ALPK1 activator for tumor immunotherapy developed by Pyrotech Therapeutics has obtained IND clearance from the FDA

2023-11-24
Pyrotech Therapeutics Announces Completion of 700 Million RMB Series A Financing

2023-07-10
Dr. Feng Shao Receives the 2022 The William B. Coley Award

2022-09-28

Media Contacts

+8610 8193 8000

info@pyrotech.com